首页> 外文期刊>Parasitology Research >Evaluation of an antigen-ELISA in the diagnosis of bovine cysticercosis in Kenyan cattle.
【24h】

Evaluation of an antigen-ELISA in the diagnosis of bovine cysticercosis in Kenyan cattle.

机译:抗原ELISA在肯尼亚牛牛囊尾diagnosis病诊断中的评估。

获取原文
获取原文并翻译 | 示例
           

摘要

A monoclonal antibody-based antigen-ELISA (Ag-ELISA) was studied in Kenyan cattle with the objective of evaluating its reliability in diagnosing bovine cysticercosis. A total of 55 cattle divided into artificially (n = 30) and naturally (n = 25) infested animals, were utilized. Total dissection was used as a gold standard of validity at autopsy. In natural infestations, the assay identified 16 cases as true seropositives, 2 cases as false seropositives, 3 cases as true seronegatives and 4 cases as false seronegatives. While in artificial infestations, the assay identified 9 cases as true seropositives, 14 cases as true seronegatives and 7 cases as false seronegatives. There weren't any false seropositive cases identified with artificial infestations. The assay showed good precision level and kappa level in quantifying the relative quality of the amount of agreement in natural (n = 25; k = 0.482; p > 0.05) and artificial (n = 24; k = 0.374; p > 0.05) infestations. The study showed that, besides other advantages, the Ag-ELISA with its sensitivity of 60.00-80.00%, specificity of 60.00-100%, predictive value of 88.89-100%, apparent prevalence of 37.50-72.00% and accuracy of 75.00-76.00% may be recommended for use in combination with other control measures, viz chemotherapy, post-mortem diagnosis and or vaccination.
机译:在肯尼亚的牛中研究了基于单克隆抗体的抗原ELISA(Ag-ELISA),旨在评估其在诊断牛囊尾rc病中的可靠性。总共使用了55头牛,分为人工(n = 30)和自然(n = 25)受感染的动物。将全解剖作为尸检时有效性的金标准。在自然侵染中,该检测方法鉴定出16例为真正的血清阳性,2例为假血清阳性,3例为血清阳性,4例为血清阴性。在人为侵染时,该测定法鉴定出9例为真正的血清阳性,14例为真正的血清阴性,7例为假血清阴性。没有人为感染的假血清反应阳性病例。该方法在量化自然(n = 25; k = 0.482; p> 0.05)和人工(n = 24; k = 0.374; p> 0.05)侵染时协议数量的相对质量方面显示出良好的精确度和kappa水平。 。研究表明,除其他优点外,Ag-ELISA的灵敏度为60.00-80.00%,特异性为60.00-100%,预测值为88.89-100%,表观患病率为37.50-72.00%,准确度为75.00-76.00可能建议将%与其他控制措施结合使用,即化学疗法,验尸诊断和/或接种疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号